Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Lozenge to Reduce S. Mutans in Orthodontic Patients
NCT02357771Phase 3Completed
- Start
- Apr 2015
- Primary completion
- Aug 2015
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 3 trial of lactobacillus brevis cd2 in Enamel demineralization. Started Apr 2015; status: completed.
02
Drugs
lactobacillus brevis cd2
03
Conditions
Enamel demineralization
Beyond the preview
Go deeper on NCT02357771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357771.